Brief: C4x Discovery In 414 Mln Euro Licensing Agreement With Sanofi For C4XD Oral IL-17A Inhibitor Programme
April 12 (Reuters) - C4X Discovery Holdings PLC C4XD.L :
* C4X DISCOVERY - SANOFI AGREEMENT
* C4X DISCOVERY - UP TO EUR 414 MILLION EXCLUSIVE WORLDWIDE
LICENSING AGREEMENT WITH SANOFI FOR C4XD ORAL IL-17A INHIBITOR
PROGRAMME
Source text for Eikon: ID:nRSL0457Va
Further company coverage: C4XD.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on C4X Discovery Holdings
See all newsC4X Discovery - Holding(s) in Company
C4X Discovery - Director/PDMR Share Purchases
C4X Discovery - Holding(s) in Company
Brief: C4x Discovery Holdings Seeks Voluntary Delisting From LSE AIM Market
Brief: C4x Discovery Holdings Proposes Voluntary Cancellation Of Admission Of Ordinary Shares To Trading On Aim